EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing the Therapeutic Efficacy of Berberine and Quercetin Through Salt Formulation for Liver Fibrosis Treatment

Yangyang Cheng, Haoyang Yu, Sitong Yang, Xiaolian Tian, Mengyu Zhao, Ling Ren, Xiuping Guo iD, Chujuan Hu, Jiandong Jiang, Lulu Wang

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26052193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yangyang Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China. Hauptthemen laut MEDLINE: Berberine, Quercetin, Liver Cirrhosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis, caused by chronic hepatic injury, is a major threat to human health worldwide, as there are no specific drugs available for its treatment. Natural compounds, such as berberine (BBR) and quercetin (QR), have shown the ability to regulate energy metabolism and protect the liver without significant adverse effects. Additionally, combination therapy (the cocktail therapy approach), using multiple drugs, has shown promise in treating complicated conditions, including liver injury. In this study, we prepared a salt formulation of BBR and QR (BQS) to enhance their combined effect on liver fibrosis. The formation of BQS was confirmed using various analytical techniques, including nuclear magnetic resonance spectroscopy (NMR), differential scanning calorimetry (DSC), Fourier-transform infrared spectroscopy (FTIR), powder X-ray diffractometry (PXRD), and scanning electron microscopy (SEM). The results demonstrated that the dissolution efficiency and bioavailability of QR significantly increased in the BQS form, aligning with that of BBR, compared to the physically mixed (BQP) form. Moreover, BQS exhibited a superior inhibitory effect on fibrosis compared to BQP in the human hepatic stellate cell line LX-2 by modulating lipid accumulation, inflammation, apoptosis, and the cell cycle. Furthermore, in a mouse model of hepatic fibrosis induced by methionine and choline-deficient (MCD) diets, BQS demonstrated enhanced anti-fibrotic activities compared to BQP. These findings suggest that BQS holds promise as a potential alternative treatment for liver fibrosis. Importantly, this study provides novel insights into achieving a cocktail effect through the salt formation of two or more drugs. The results highlight the potential of salt formulations in enhancing the therapeutic efficacy and consistent biological processes of drug combinations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineQuercetinLiver CirrhosisAnimalsHumansMiceCell LineMaleDisease Models, AnimalHepatic Stellate CellsApoptosisDrug CompoundingLiver

Stichwörter der Autor:innen

berberinecocktail therapyliver fibrosisquercetin

Substanzen

BerberineQuercetin

Autor:innen und Institutionen

  • Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China.

ORCID-Profile: Xiuping Guo

Förderung

  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Cheng, Y., Yu, H., Yang, S., Tian, X., Zhao, M., Ren, L., Guo, X., Hu, C., Jiang, J., & Wang, L. (2025). Enhancing the Therapeutic Efficacy of Berberine and Quercetin Through Salt Formulation for Liver Fibrosis Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052193

Vancouver

Cheng Y, Yu H, Yang S, Tian X, Zhao M, Ren L, et al. Enhancing the Therapeutic Efficacy of Berberine and Quercetin Through Salt Formulation for Liver Fibrosis Treatment. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052193

BibTeX
@article{Cheng2025,
  author = {Cheng, Yangyang and Yu, Haoyang and Yang, Sitong and Tian, Xiaolian and Zhao, Mengyu and Ren, Ling and Guo, Xiuping and Hu, Chujuan and Jiang, Jiandong and Wang, Lulu},
  title = {Enhancing the Therapeutic Efficacy of Berberine and Quercetin Through Salt Formulation for Liver Fibrosis Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26052193}
}
Kostenlos starten →